Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
Novavax reported Q4 sales of $88.31 million, beating estimates despite a decline. The company shifts focus to partnerships ...
H.C. Wainwright downgraded Lava Therapeutics (LVTX) to Neutral from Buy with a price target of $1.50, down from $2. The company announced a ...
H.C. Wainwright lowered the firm’s price target on Harmony Biosciences (HRMY) to $70 from $75 and keeps a Buy rating on the shares following ...
Summit Therapeutics (NASDAQ:SMMT – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at HC ...
NovoCure Limited (NASDAQ:NVCR – Get Free Report) has been given an average recommendation of “Moderate Buy” by the six research firms that are presently covering the company, MarketBeat.com reports.
Fintel reports that on February 26, 2025, HC Wainwright & Co. upgraded their outlook for Arcus Biosciences (NYSE:RCUS) from ...
Fintel reports that on February 26, 2025, HC Wainwright & Co. downgraded their outlook for Geron (NasdaqGS:GERN) from Buy to ...